Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty.

[1]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[2]  N L Geller,et al.  Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG. , 1995, Circulation.

[3]  A. Gershlick,et al.  The Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome. , 1995, Journal of the American College of Cardiology.

[4]  Samin K. Sharma,et al.  Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. , 1994, Journal of the American College of Cardiology.

[5]  A. Gershlick,et al.  Absence of a prothrombotic state in restenotic patients? , 1994, Coronary artery disease.

[6]  C. Dunwiddie,et al.  Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. , 1994, Circulation.

[7]  A. Manolis,et al.  Plasma level changes of fibrinopeptide a after uncomplicated coronary angioplasty , 1993, Clinical cardiology.

[8]  V. Fuster,et al.  Thrombosis in Cardiovascular Disorders , 1992, Annals of Internal Medicine.

[9]  D. Collen,et al.  Plasma Fibrinopeptide A Levels in Patients With Acute Myocardial Infarction Treated With Alteplase: Correlation With Concomitant Heparin, Coronary Artery Patency, and Recurrent Ischemia , 1992, Circulation.

[10]  V. Fuster,et al.  Antithrombotic Therapy for Deep Arterial Injury by Angioplasty: Efficacy of Common Platelet Inhibition Compared With Thrombin Inhibition in Pigs , 1991, Circulation.

[11]  W. Roberts,et al.  Effectiveness of Recombinant Desulphatohirudin in Reducing Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits , 1991, Circulation.

[12]  A. Jacobs,et al.  Detection of intracoronary fibrin degradation after coronary balloon angioplasty. , 1991, The American journal of cardiology.

[13]  V. Fuster,et al.  The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[14]  V. Fuster,et al.  Importance of antithrombin therapy during coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[15]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[16]  M. Kuzuya,et al.  Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. , 1990, Atherosclerosis.

[17]  W. Laskey,et al.  Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus. , 1990, The American journal of cardiology.

[18]  H. Gold,et al.  Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. , 1990, Circulation.

[19]  M. Richardson,et al.  Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface. Correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium. , 1989, The American journal of pathology.

[20]  S. Ellis,et al.  Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. , 1989, American heart journal.

[21]  W J Penny,et al.  Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. , 1989, Circulation.

[22]  L Schwartz,et al.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. , 1988, The New England journal of medicine.

[23]  L. Hillis,et al.  Restenosis after successful coronary angioplasty. Pathophysiology and prevention. , 1988, The New England journal of medicine.

[24]  E. Bolson,et al.  Percutaneous transluminal coronary angioplasty and subsequent restenosis: quantitative and qualitative methodology for their assessment. , 1987, The American journal of cardiology.

[25]  M. Bettmann.  Anticoagulation and restenosis after percutaneous transluminal coronary angioplasty. , 1987, The American journal of cardiology.

[26]  L. Harker,et al.  Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. , 1987, The American journal of cardiology.

[27]  V. Fuster,et al.  Restenosis after arterial angioplasty: a hemorrheologic response to injury. , 1987, The American journal of cardiology.

[28]  T. Ryan,et al.  Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. , 1987, Circulation.

[29]  R. Ross,et al.  Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells , 1986, The Journal of cell biology.

[30]  A. Haeberli,et al.  Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction. , 1984, Circulation.

[31]  K. Tanaka.  [Thrombosis and fibrinolysis]. , 1969, Rinsho byori. The Japanese journal of clinical pathology.